News & Events

Genoox Names Andy Page to lead its Advisory Board

The seasoned technology executive and former president of 23andMe will enrich Genoox's mission to build the most diverse genomic database to support point of care geneticists

Read More

The Genoox Quest to build the largest real-world evidence dataset

Creating the world’s largest genomic database powered by real world evidence answering any clinical and genetic questions by harnessing the power of the community to and serving healthcare professionals, clinicians, genetic experts and pharma to enhance patient care.

Read More

Element Biosciences Partners with Interpretation Expert Genoox to Validate the AVITI™ System for the RUGD Application

Demonstrating the clinical potential of the AVITI system for rare and undiagnosed disease research, using whole genome sequencing.

Read More

Forbes: “How This Tech Company Allows Medical Professionals To Practice Precision Medicine”

Our story about building the world’s largest, most diverse real-world evidence dataset to answer any genomic question.

Read More

Genoox to Provide Genomic Data Analysis Platform at Washington University in St. Louis

Genoox leverages its community-driven AI software to enable analysis and facilitate interpretation of genetic and genomic testing spanning clinical and research domains.

Read More

Genoox and Aspira Women’s Health Inc. Partner to Develop and Deliver Data-Driven Insights to Advance Women’s Health

This partnership will expand on the information currently available to establish and improve advanced testing to accurately diagnose complex diseases found in women

Read More

Genoox selected as one of the top 5 startups disrupting healthcare in genomics

The company’s mission — to democratize healthcare — will help health systems provide more standardized care, regardless of location, which can aid in better patient outcomes

Read More

Healthcare investor Triventures backs genomics company Genoox in $6 million funding round

Genoox seeks to advance precision medicine through its next-generation sequencing technology and genomic data analytics.

Read More

Triventures, Leading Healthcare Investor, Backs Genoox in $6 Million Funding Round

PALO ALTO, Calif. – (Business Wire) – Genoox, a genomic analysis company making it easier for doctors, clinicians and researchers to analyze and act on genetic sequencing results by applying various clinical applications, today announced it closed a $6 million funding round. The round was led by Triventures, a venture capital fund that invests in…

Read More

Genoox, Bionano Genomics Partner to Improve DNA Structural Variant Disease Detection

NEW YORK (GenomeWeb) – Genoox announced today that it has partnered with Bionano Genomics to develop a genome informatics workflow, which will integrate and annotate Bionano’s structural variant calls with sequencing data within the Genoox platform.

Read More

Michigan genomic research lab protects data with de-indentifier, multilayer platform

The Genoox platform helps the team apply standards for both security policies and sharing data across the community, which has the benefit of increasing cooperation between organizations.

Read More

The Importance Of Data Governance In The Future Of Healthcare

Genoox will analyze genetic data captured and provide actionable insights to hospitals, clinical labs and researchers throughout Israel

Read More

Genoox Betting On Variant Classification Tech to Bring More NGS to Community Hospitals

Genoox has developed an artificially intelligent engine to classify genetic variants, based on American College of Medical Genetics and Genomics guidelines. This platform provides data analytics services to physicians and researchers looking to integrate genomic sequencing information into clinical workflows, and Genoox has said its technology can lower sequencing costs by as much as 90…

Read More

Contact Us

If you’d like to chat about Genoox in more detail, complete this form
and we’ll get back to you.